Hexagon Nutrition IPO
Bookbuilding IPO | ₹139.00 Cr | Listing at BSE, NSE
Upcoming
IPO Open
Fri, Jun 05, 2026
IPO Close
Tue, Jun 09, 2026
Price Band
₹42.00 to ₹45.00
Market Cap (Pre-IPO)
₹553.13 Cr
IPO Details
| IPO Date | Jun 05, 2026 to Jun 09, 2026 |
| Listing Date | Tentative: Jun 12, 2026 |
| Face Value | ₹1.00 per share |
| Price Band | ₹42.00 to ₹45.00 |
| Lot Size | 333 Shares (Minimum: ₹14,985.00) |
| Sale Type | Offer For Sale |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Issue Size | ₹139.00 Crores |
| Total Shares Offered | 30,859,704 shares |
| Fresh Issue | 30,859,704 shares |
| Offer For Sale | 30,859,704 shares |
Hexagon Nutrition IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50.00% of the Net Offer |
| Retail Shares Offered | Not less than 35.00% of the Net Offer |
| NII Shares Offered | Not less than 15.00% of the Net Offer |
Hexagon Nutrition IPO Lot Size
Investors can bid for a minimum of 333 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 333 | ₹14,985 |
| Retail (Max) | 13 | 4,329 | ₹194,805 |
| S-HNI (Min) | 14 | 4,662 | ₹209,790 |
| S-HNI (Max) | 66 | 21,978 | ₹989,010 |
| B-HNI (Min) | 67 | 22,311 | ₹1,003,995 |
Hexagon Nutrition Financial Information (Restated Consolidated)
| Period Ended | 31 Dec 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 327.60 | 261.36 | 250.54 | 288.90 |
| Total Income | 275.57 | 331.29 | 304.62 | 281.65 |
| Profit After Tax | 27.03 | 24.38 | 12.21 | 5.82 |
| EBITDA | 37.55 | 40.07 | 24.88 | 17.17 |
| NET Worth | 223.05 | 195.60 | 176.29 | 163.84 |
| Reserves and Surplus | 210.92 | 183.89 | 164.51 | 152.30 |
| Total Borrowing | 39.79 | 26.60 | 36.89 | 51.87 |
Amount in ₹ Cr
Key Performance Indicators
As of Monday, March 31, 2025| KPI | Values |
|---|---|
| ROE (Return on Equity) | 10.47% |
| ROCE (Return on Capital Employed) | 17.06% |
| Debt/Equity | 0.14 |
| RoNW (Return on Net Worth) | 12.46% |
| PAT Margin (Profit After Tax Margin) | 7.36% |
| EBITDA Margin | 12.33% |
| Price to Book Value | 2.83 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 1.98 | 2.93 |
| P/E (x) | 22.69 | 15.35 |
| Promoter Holding | 89.41% | 64.29% |
Company Promoters
- Arun Purushottam Kelkar
- Subhash Purushottam Kelkar
- Vikram Arun Kelkar and Nikhil Arun Kelkar.
Company Overview
Hexagon Nutrition – Company Overview
- Incorporated in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition company engaged in the development and manufacturing of clinical nutrition, wellness products, micronutrient premixes, and therapeutic formulations.
Core Segments
- Branded Wellness & Clinical Nutrition (B2C): Nutritional and therapeutic health products
- Premix Formulations (B2B2C): Micronutrient premixes for food and healthcare industries
- RUFs & MNPs: Ready-to-Use Foods and Micronutrient Powders under ESG initiatives
- The company operates three manufacturing facilities in India located at Nasik, Chennai, and Thoothukudi, along with an international facility in Tashkent, Uzbekistan.
- Its products are distributed through a PAN-India omnichannel network, including retail pharmacies, hospitals, e-commerce platforms, and branded websites such as Pentasure, Obesigo, Pediagold, and Nutrone.
- Hexagon Nutrition works with over 358 distributors across India and exports products to more than 75 countries across Asia, Africa, Europe, and South America.
- The company has overseas offices in South Africa, Uzbekistan, and Hong Kong to support international business operations.
- It maintains dedicated in-house R&D facilities at Nasik and Chennai focused on product innovation and nutritional research.
- As of March 31, 2026, the company had 527 employees.
Hexagon Nutrition IPO Peer Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|---|
| Hexagon Nutrition | 1.75 | 1.75 | 15.91 | - | 12.46 | - | - |
| Zydus Wellness Ltd | 10.90 | 10.90 | 178.26 | 46.22 | 6.12 | - | - |
| Nestle India Ltd | 16.63 | 16.63 | 21.35 | 88.86 | 77.91 | - | - |
Quick Info
| Sector | Nutraceutical and Healthcare |
| Exchange | BSE, NSE |
| Market Cap (Pre-IPO) | ₹553.13 Cr |
Important Dates
| IPO Open | Jun 05, 2026 |
| IPO Close | Jun 09, 2026 |
| Allotment Date | Jun 10, 2026 |
| Credit to Demat | Jun 11, 2026 |
| Listing Date | Tentative: Jun 12, 2026 |
Lead Manager(s)
Cumulative Capital Pvt.Ltd.
Registrar
Kfin Technologies Ltd.
04067162222, 04079611000
Description
- IPO Type: Book build issue aggregating to ₹138.87 crores.
- Issue Structure: Entirely an Offer for Sale (OFS) of 3.09 crore shares totaling ₹138.87 crores.
- IPO Dates: The issue opens on June 5, 2026 and closes on June 9, 2026.
- Allotment Date: Expected to be finalized on June 10, 2026.
- Listing Details: Shares are proposed to be listed on National Stock Exchange of India (NSE) and BSE Limited (BSE) with a tentative listing date of June 12, 2026.
- Retail Investment Requirement: Minimum 1 lot (333 shares) amounting to approximately ₹14,985 (at upper price band).
- sNII Investment Requirement: Minimum 14 lots (4,662 shares) totaling around ₹2,09,790.
- bNII Investment Requirement: Minimum 67 lots (22,311 shares) totaling around ₹10,03,995.
- IPO Price Band: ₹42 to ₹45 per equity share.
- Lot Size: 333 shares per lot.
This IPO offers investors an opportunity to participate in the nutrition and healthcare products sector, subject to market risks.